Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Genotype 1”

550 trials

Showing 20 of 550 results

Testing effectiveness (Phase 2)Study completedNCT01466790
What this trial is testing

TMC435 in Combination With PSI-7977 (GS7977) in Chronic Hepatitis C Genotype 1-Infected Prior Null Responders To Peginterferon/Ribavirin Therapy or HCV Treatment-Naive Patients

Who this might be right for
Hepatitis C
Janssen R&D Ireland 168
Testing effectiveness (Phase 2)Study completedNCT01987453
What this trial is testing

Ledipasvir/Sofosbuvir Fixed-Dose Combination ± Ribavirin in Participants With Chronic Genotype 1 HCV Who Participated in a Prior Gilead-Sponsored HCV Treatment Study

Who this might be right for
HCV Infection
Gilead Sciences 100
Large-scale testing (Phase 3)Ended earlyNCT02478229
What this trial is testing

Early Treatment With Sofosbuvir (SOF) and Ledipasvir (LDV) to Prevent HCV Recurrence After Liver Transplantation (OLT)

Who this might be right for
Hepatitis C Viral Infection
University Health Network, Toronto 1
Large-scale testing (Phase 3)Study completedNCT02105467
What this trial is testing

Study of Efficacy and Safety of Grazoprevir (MK-5172)/Elbasvir (MK-8742) Combination Regimen for Treatment-Naïve Participants With Chronic Hepatitis C Virus Genotypes 1, 4, and 6 (MK-5172-060)

Who this might be right for
Chronic Hepatitis C Virus
Merck Sharp & Dohme LLC 421
Testing effectiveness (Phase 2)Study completedNCT01849562
What this trial is testing

Safety, Tolerability, and Efficacy of 12-weeks of Sovaprevir, ACH-3102, and Ribavirin in Treatment-naive GT-1 HCV Participants

Who this might be right for
Hepatitis C, Chronic
Alexion Pharmaceuticals, Inc. 30
Testing effectiveness (Phase 2)Study completedNCT01482403
What this trial is testing

Mericitabine in Combination With Boceprevir and Pegasys/Copegus in Patients With Chronic Hepatitis C

Who this might be right for
Hepatitis C, Chronic
Hoffmann-La Roche 58
Post-approval studies (Phase 4)Ended earlyNCT00493805
What this trial is testing

Study of Response in Chronic Hepatitis C (CHC) Participants Genotype 1 With Insulin Resistance and Prolonged Treatment Duration in Late Responders (P04823/MK-4031-303)

Who this might be right for
Hepatitis C, ChronicInsulin Resistance
Merck Sharp & Dohme LLC 59
Not applicableStudy completedNCT04189627
What this trial is testing

The Effectiveness and Clinical Practice Use of Glecaprevir/Pibrentasvir in Adolescents With Chronic Hepatitis C Genotypes 1 to 6 in Russian Federation

Who this might be right for
Hepatitis C Virus (HCV)
AbbVie 99
Not applicableStudy completedNCT01054742
What this trial is testing

Observational Study of Patients With Chronic Hepatitis C Virus (HCV) Infected With HCV Genotype 1 Low Virus Load (LVL 1) and Effect of PegIntron Plus Rebetol Treatment (Study P04793 Part 2)

Who this might be right for
Hepatitis C
Merck Sharp & Dohme LLC 2
Testing effectiveness (Phase 2)Study completedNCT01899092
What this trial is testing

Safety and Efficacy Study of Single Doses of TT-034 in Patients With Chronic Hepatitis C

Who this might be right for
Hepatitis C
Tacere Therapeutics, Inc. 9
Early research (Phase 1)Study completedNCT01081158
What this trial is testing

Safety, Tolerability, PK and PD of SCH 900518 in Naive or Treatment-Experienced Subjects Infected With HCV Genotype 1 (Protocol No. P04695)

Who this might be right for
Hepatitis C, Chronic
Merck Sharp & Dohme LLC 41
Large-scale testing (Phase 3)Study completedNCT00237484
What this trial is testing

Effect of Infliximab on the Efficacy of Peg-Intron/Ribavirin in Patients With Hepatitis C (Study P04257AM4)(COMPLETED)

Who this might be right for
Hepatitis C, Chronic
Merck Sharp & Dohme LLC 89
Testing effectiveness (Phase 2)Study completedNCT01458535
What this trial is testing

Evaluate Paritaprevir With Ritonavir (ABT-450/r) When Given Together With Ombitasvir and With and Without Ribavirin (RBV) in Treatment-Naïve Participants With Genotype 1, 2 or 3 Chronic Hepatitis C Virus (HCV)

Who this might be right for
Hepatitis C Virus
AbbVie (prior sponsor, Abbott) 61
Testing effectiveness (Phase 2)Study completedNCT01030432
What this trial is testing

Study of BMS-650032 With Peginterferon Alfa-2a Plus Ribavirin

Who this might be right for
Hepatitis C Virus
Bristol-Myers Squibb 285
Not applicableEnded earlyNCT02315638
What this trial is testing

Long-Term Follow-Up Safety Monitoring of Patients Dosed in the First-in-Man Phase I/II Study of TT-034.

Who this might be right for
Hepatitis C
Tacere Therapeutics, Inc. 9
Large-scale testing (Phase 3)Study completedNCT01485991
What this trial is testing

TMC435HPC3001 - An Efficacy, Safety and Tolerability Study for TMC435 vs Telaprevir in Combination With PegINFα-2a and Ribavirin in Chronic Hepatitis C Patients Who Were Null or Partial Responders to Prior PegINFα-2a and Ribavirin Therapy

Who this might be right for
Hepatitis C
Janssen R&D Ireland 771
Testing effectiveness (Phase 2)Study completedNCT01180790
What this trial is testing

Safety, Tolerability, and Antiviral Activity of ACH-0141625 or Placebo in Combination With Peginterferon and Ribavirin in Hepatitis C Virus (HCV) Positive Participants

Who this might be right for
Hepatitis C
Alexion Pharmaceuticals, Inc. 122
Testing effectiveness (Phase 2)Study completedNCT02165189
What this trial is testing

An Efficacy and Safety Study of Simeprevir and Sofosbuvir With and Without Ribavirin in Participants With Recurrent Genotype 1 Hepatitis C Post-Orthotopic Liver Transplant

Who this might be right for
Hepatitits C
Janssen Scientific Affairs, LLC 46
Post-approval studies (Phase 4)UnknownNCT04997564
What this trial is testing

The Efficacy and Safety of 12-week SOF/VEL Regimen Combined With Prophylactic Use of TAF for Treatment-naïve Genotype 1-6 HCV/HBV Co-infection Adult Patients With or Without Compensated Cirrhosis in China

Who this might be right for
Chronic Hepatitis CChronic Hepatitis B
Peking University First Hospital 120
Early research (Phase 1)WithdrawnNCT01525212
What this trial is testing

Multiple Ascending Dose Study of BMS-929075 in Hepatitis C Virus (HCV) Infected Patients

Who this might be right for
Chronic Hepatitis C
Bristol-Myers Squibb
Load More Results

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation